Yves Dauvilliers Selected Research

Hypnotics and Sedatives (Sedatives)

1/2023	Association between hypersomnolence and the COVID-19 pandemic: The International COVID-19 Sleep Study (ICOSS).
1/2022	Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderly.
12/2021	Sleep and daytime problems during the COVID-19 pandemic and effects of coronavirus infection, confinement and financial suffering: a multinational survey using a harmonised questionnaire.
2/2017	Hypersomnolence, Hypersomnia, and Mood Disorders.
9/2013	Hypnotics and mortality in an elderly general population: a 12-year prospective study.
12/2004	[Narcolepsy, from Westphal to hypocretin].
12/2004	Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yves Dauvilliers Research Topics

Disease

130	Narcolepsy 05/2024 - 01/2003
73	Cataplexy 11/2023 - 02/2002
66	Disorders of Excessive Somnolence (Hypersomnia) 01/2024 - 01/2004
30	Sleepiness 01/2024 - 04/2008
23	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2024 - 12/2004
19	Sleep Wake Disorders 01/2024 - 01/2005
15	Parkinson Disease (Parkinson's Disease) 03/2024 - 12/2011
11	Dementia (Dementias) 01/2023 - 01/2004
10	Idiopathic Hypersomnia 01/2024 - 10/2010
10	Headache (Headaches) 01/2023 - 06/2011
10	Restless Legs Syndrome (Restless Legs) 12/2020 - 03/2007
8	Obstructive Sleep Apnea 11/2023 - 12/2014
7	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 07/2015
7	REM Sleep Behavior Disorder 01/2022 - 10/2013
5	Parkinsonian Disorders (Parkinsonism) 10/2022 - 03/2011
5	Kleine-Levin Syndrome (Syndrome, Kleine-Levin) 01/2022 - 12/2006
5	Hallucinations (Hallucination) 01/2022 - 01/2004
5	Synucleinopathies 01/2022 - 01/2017
5	Nausea 01/2020 - 09/2016
5	Sleep Paralysis 10/2019 - 05/2010
4	Apnea 06/2023 - 08/2009
4	Sleep Apnea Syndromes (Sleep Apnea) 01/2023 - 08/2009
4	Parasomnias (Parasomnia) 01/2022 - 11/2015
4	Sleep Deprivation 01/2022 - 12/2010
4	Fatigue 12/2021 - 01/2017
4	Human Influenza (Influenza) 10/2017 - 08/2013
3	Stroke (Strokes) 01/2024 - 12/2011
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023 - 01/2003
3	Inflammation (Inflammations) 01/2023 - 01/2016
3	Cognitive Dysfunction 01/2022 - 09/2012
3	Nasopharyngitis 01/2020 - 01/2018
3	Multiple System Atrophy 01/2018 - 03/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2022
2	COVID-19 01/2023 - 01/2023
2	Somnambulism (Sleepwalking) 01/2022 - 11/2015
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2019
2	Iron Deficiencies 11/2021 - 01/2019
2	Amyloid Plaque 01/2021 - 01/2019
2	Disease Progression 01/2021 - 12/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2011

Drug/Important Bio-Agent (IBA)

81	OrexinsIBA 05/2024 - 01/2003
35	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2023 - 12/2004
19	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2014
18	HLA-DQB1 antigen (HLA DQB1)IBA 04/2024 - 02/2002
18	Modafinil (Provigil)FDA Link 01/2023 - 01/2003
13	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2003
12	pitolisantIBA 11/2023 - 04/2008
10	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 04/2008
9	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2023 - 09/2004
7	HLA Antigens (Human Leukocyte Antigens)IBA 12/2023 - 01/2006
7	Hypnotics and Sedatives (Sedatives)IBA 01/2023 - 12/2004
7	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 03/2007
6	Peptides (Polypeptides)IBA 04/2024 - 10/2010
6	EnzymesIBA 07/2023 - 10/2010
6	solriamfetolIBA 01/2022 - 01/2019
6	Ferritins (Ferritin)IBA 01/2020 - 05/2010
5	daridorexantIBA 04/2024 - 01/2020
5	Orexin Receptor AntagonistsIBA 01/2023 - 01/2020
5	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2023 - 11/2013
5	VaccinesIBA 01/2022 - 08/2013
4	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2019
4	SolutionsIBA 01/2022 - 01/2016
4	SodiumIBA 01/2022 - 07/2021
4	CalciumIBA 01/2022 - 07/2021
4	MagnesiumIBA 01/2022 - 07/2021
4	PotassiumIBA 01/2022 - 07/2021
4	Amphetamine (Amfetamine)FDA LinkGeneric 12/2021 - 01/2013
4	Methylphenidate (Ritalin)FDA LinkGeneric 12/2021 - 01/2013
4	IronIBA 01/2020 - 11/2010
4	tele-methylhistamineIBA 01/2019 - 10/2012
3	Glucosylceramidase (Glucocerebrosidase)IBA 03/2024 - 01/2023
3	AntigensIBA 01/2024 - 12/2011
3	AutoantibodiesIBA 01/2024 - 03/2010
3	NeuropeptidesIBA 07/2023 - 04/2008
3	SynucleinsIBA 01/2022 - 11/2014
3	AutoantigensIBA 01/2022 - 03/2010
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020 - 06/2016
3	Wakefulness-Promoting AgentsIBA 01/2019 - 08/2017
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2010
3	CytokinesIBA 11/2016 - 03/2014
3	Intravenous Immunoglobulins (IVIG)FDA Link 07/2006 - 12/2004
2	HydrolasesIBA 03/2024 - 11/2023
2	Cathepsin BIBA 03/2024 - 11/2023
2	alpha-SynucleinIBA 03/2024 - 11/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2022
2	Orexin ReceptorsIBA 07/2023 - 11/2003
2	Zolpidem (Ambien)FDA LinkGeneric 01/2023 - 01/2020
2	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 01/2016
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 12/2021 - 01/2021
2	Clomipramine (Anafranil)FDA LinkGeneric 12/2021 - 01/2021
2	rotigotine FDA Link 12/2020 - 09/2016
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2020 - 01/2019
2	HepcidinsIBA 01/2020 - 01/2018
2	Flecainide (Tambocor)FDA LinkGeneric 11/2019 - 01/2016

Therapy/Procedure

14	Therapeutics 11/2023 - 12/2004
7	Continuous Positive Airway Pressure 01/2024 - 08/2009
2	Aftercare (After-Treatment) 01/2023 - 02/2022
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
2	Bed Rest (Bedrest) 01/2021 - 01/2018